Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 443.8 Million | 433.42 Million | 351.1 Million | 323.46 Million | 311.54 Million | 286.1 Million |
| Cost of Revenue | 267.53 Million | 250.76 Million | 175.28 Million | 145.48 Million | 146.51 Million | 146.08 Million |
| Gross Profit | 176.26 Million | 182.65 Million | 175.82 Million | 177.97 Million | 165.02 Million | 140.02 Million |
| Operating Expenses | 106.55 Million | 92.52 Million | 71.83 Million | 63.09 Million | 63.05 Million | 50.55 Million |
| Selling, General and Administrative Expenses | 58.6 Million | 49.35 Million | 31.18 Million | 31.47 Million | 29.46 Million | 21.03 Million |
| Research and Development Expenses | 38.59 Million | 32.29 Million | 30.94 Million | 20.38 Million | 18.72 Million | 16.37 Million |
| Other Expenses | 40.66 Million | 10.87 Million | 9.7 Million | 11.23 Million | 14.86 Million | 32.85 Million |
| Cost and Expenses | 362.19 Million | 343.28 Million | 247.12 Million | 208.58 Million | 209.57 Million | 196.64 Million |
| Operating Income | 81.6 Million | 134.55 Million | 117.15 Million | 124.2 Million | 143.56 Million | 81.02 Million |
| Interest Expense | 765.04 Thousand | 366.11 Thousand | 351.43 Thousand | 54.44 Thousand | 10.58 Thousand | 77.98 Thousand |
| Income Tax Expense | 13.63 Million | 16.55 Million | 20.76 Million | 22.79 Million | 19.99 Million | 15.97 Million |
| Earnings before Tax | 100 Million | 78.13 Million | 152.06 Million | 157.73 Million | 139.74 Million | 113.79 Million |
| Net Income | 91.37 Million | 64.37 Million | 128.57 Million | 130.58 Million | 118.17 Million | 96.98 Million |
| Earnings Per Share Basic | 0.54 | 0.38 | 0.77 | 0.78 | 0.70 | 0.77 |
| Earnings Per Share Diluted | 0.54 | 0.38 | 0.77 | 0.78 | 0.70 | 0.77 |
| Weighted Average Shares Outstanding | 169.21 Million | 167.99 Million | 167.99 Million | 167.99 Million | 167.99 Million | 125.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.21 Million | 167.99 Million | 167.99 Million | 167.99 Million | 167.99 Million | 125.72 Million |
| Gross Margin | 0.40 | 0.42 | 0.50 | 0.55 | 0.53 | 0.49 |
| EBIT Margin | 0.34 | 0.37 | 0.50 | 0.58 | 0.55 | 0.44 |
| Profit Margin | 0.21 | 0.15 | 0.37 | 0.40 | 0.38 | 0.34 |
| EBITDA | 152.91 Million | 113.91 Million | 178.01 Million | 135.77 Million | 169.88 Million | 117.29 Million |
| Earnings Before Tax Margin | 0.18 | 0.31 | 0.33 | 0.38 | 0.46 | 0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 126.31 Million | 143.81 Million | 117.02 Million | 120.63 Million | 445.46 Million | 126.06 Million |
| Cost of Revenue | 82.08 Million | 81.41 Million | 69.63 Million | 64.56 Million | 255.64 Million | 73.88 Million |
| Gross Profit | 44.23 Million | 62.39 Million | 47.38 Million | 56.07 Million | 189.82 Million | 52.17 Million |
| Operating Expenses | 28.66 Million | 21.41 Million | 25.21 Million | 88.54 Million | 363.13 Million | 27.62 Million |
| Selling, General and Administrative Expenses | 30.46 Million | 5.51 Million | 15.2 Million | -9.94 Million | - | 25.76 Million |
| Research and Development Expenses | 12.41 Million | 11.43 Million | 10.44 Million | 10.38 Million | - | 10.37 Million |
| Other Expenses | -14.2 Million | 2.57 Million | 4.59 Million | -88.54 Million | -363.13 Million | 5.73 Million |
| Cost and Expenses | 110.74 Million | 102.82 Million | 94.85 Million | 88.54 Million | 363.13 Million | 101.51 Million |
| Operating Income | 12.43 Million | 47.39 Million | 23.47 Million | 32.09 Million | 82.33 Million | 21.04 Million |
| Interest Expense | 93.91 Thousand | 109.18 Thousand | 115.73 Thousand | 111.56 Thousand | 595.48 Thousand | 77.83 Thousand |
| Income Tax Expense | 1.4 Million | 7.32 Million | 4.38 Million | 5.17 Million | 13.63 Million | 2.41 Million |
| Earnings before Tax | 16.24 Million | 49.97 Million | 28.06 Million | 35.76 Million | 101.35 Million | 26.77 Million |
| Net Income | 16 Million | 43.57 Million | 24.31 Million | 30.95 Million | 91.37 Million | 25.56 Million |
| Earnings Per Share Basic | 0.09 | 0.26 | 0.14 | 0.18 | - | 0.15 |
| Earnings Per Share Diluted | 0.09 | 0.26 | 0.14 | 0.18 | - | 0.15 |
| Weighted Average Shares Outstanding | 172.98 Million | 172.98 Million | 173.66 Million | 174.47 Million | 169.21 Million | 168.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 172.98 Million | 172.98 Million | 173.66 Million | 174.47 Million | 169.21 Million | 168.3 Million |
| Gross Margin | 0.35 | 0.43 | 0.40 | 0.46 | 0.43 | 0.41 |
| EBIT Margin | 0.13 | 0.31 | 0.23 | 0.33 | - | 0.24 |
| Profit Margin | 0.13 | 0.30 | 0.21 | 0.26 | 0.21 | 0.20 |
| EBITDA | 16.34 Million | 45.25 Million | 27.43 Million | 40.36 Million | - | 30.15 Million |
| Earnings Before Tax Margin | 0.10 | 0.33 | 0.20 | 0.27 | 0.18 | 0.17 |
RELAXO
002922
TRI
HLUN-A
KRIDHANINF
SDXOF